Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with α1-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts

British Journal of Clinical Pharmacology, Supplement

Volumn 52, Issue 3, 2001, Pages 279-287

  Liu, Ming Hui ^a   Floten, Storm H ^a   Yang, Qin ^b,c   He, Guo Wei ^a,b,c  

^a PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

AJ 2615; Calcium channel antagonist; Coronary artery bypass grafting; Internal mammary artery; 1 adrenergic receptor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIBENZOTHIEPIN DERIVATIVE; ENDOTHELIN 1; METHOXAMINE; MONATEPIL; NORADRENALIN; PIPERAZINE DERIVATIVE; POTASSIUM CHLORIDE; PRAZOSIN; SEROTONIN; VASOCONSTRICTOR AGENT;

AGED; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; MALE; MAMMARY ARTERY; MIDDLE AGED; PHYSIOLOGY; VASOCONSTRICTION; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADRENERGIC ALPHA-ANTAGONISTS; AGED; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERY BYPASS; DIBENZOTHIEPINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; METHOXAMINE; MIDDLE AGED; NOREPINEPHRINE; PIPERAZINES; POTASSIUM CHLORIDE; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; SEROTONIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0035464364     PISSN: 02643774     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01444.x     Document Type: Article

References (28)

1. He GW. Verapamil plus nitroglycerin solution maximally preserves endothelial function of the radial artery: Comparison with papaverine solution. J Thorac Cardiovasc Surg 1998; 115: 1321-1327.
2. He GW, Yang CQ. Comparison of nitropmsside and nitroglycerin in inhibition of angiotension II and other vasoconstrictor-mediated contraction in human coronary bypass conduits. Br J Clin Pharmacol 1997; 44: 361-367.
3. He GW, Rosenfeldt FL, Buxton BF, Angus JA. Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery-spasm. Circulation 1989; 80: 1141-1150.
4. Kurokawa M, Sato F, Hatano N, Honda Y, Uno H. A new class of calcium antagonists. Synthesis and biological activity of 11-[(omega-aminoalkanoyl) -amino]-6, 6a,7, 8, 9, 10, 10a, 11-octahydrodibenzo [b, e]-thiepin derivatives. J Med Chem 1991; 34: 593-599.
5. 2+ entry blocker, AJ-2615, in vitro. J Cardiovasc Pharmacol 1993; 22: 804-809.
6. 1-adrenergic blocking activity in experiental hypertensive animals. J Cardiovasc Pharmacol 1993; 21: 815-821.
7. Sasaki J, Ogihara T, Yokoyama M, et al. Comparative effects of monatepil, a novel calcium antagonist with a|-adrnergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension. AmJ Hypertension 1994; 7: S161-S166.
8. Loop FD. Internal-thoracic-artery grafts: Biologically better coronary arteries. N EiiglJ Mcd 1996; 334: 263-265.
9. Lytle BW, McElroy D, McCarthy P. Influence of arterial coronary bypass grafts on the mortality in coronary reoperations. J Tliorac Cardioi'asc Snrg 1994; 107: 675-682.
10. Chardigny C, Jebara VA, Acar C. Vasoreactivity of the radial artery: Comparison with the internal mammary and gastroepiploic arteries with implications for coronary artery surgery. Circulation 1993; 88: 115-127.
11. Izzat MB, West RR, Ragoonanan C, Angelini GD. Effect of systemic vasodilators on internal mammary artery flow.J Tliorac Cardiovasc Smg 1994; 108: 82-85.
12. Sasson L, Cohen AJ, Hauptman E, Schachner A. Effects of topic vasodilators on internal mammary arteries. Ann Tliorac Snrg 1995; 59: 494-496.
13. He GW, Yang CQ. Effects of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery. J Cardiovasc Pliannacol 1995; 26: 13-19.
14. He GW, Yang CQ, Gately H, et ai. Potential greater than additive vasorelaxation actions of milrinone and nitroglycerin on human conduit arteries. BrJ Clin Pliannacol 1996; 41: 101-107.
15. He GW, Acuff TE, Ryan WH, et al. Inhibitory effects of calcium antagonists on a-adrenoceptor-mediated contraction in the human internal mammary artery. Br J Clin Pliannacol 1994; 37: 173-179.
16. 1-adrenoceptor-niediated contraction in the human internal mammary artery. J Cardovasc Pharmacol 1993; 21: 256-263.
17. He GW, Buxton 13, Rosenfeldt F, Wilson AC, Angus JA. Weak β-adrenoceptor-mediated relaxation in the human internal mammary artery. J Tliorac Cardiovasc Surg 1989; 97: 256-266.
18. Liu M-H, Jin H-K, Floten HS, et al. Vascular endothelial growth factor mediated endothelium-dependent relaxation is blunt in spontaneously hypertensive rat aorta. J Plmrmacol Exp Ther 2001; 296: 473-477.
19. He GW, Yang CQ, Graier WF, Yang JA. Hyperkalemia alters EDHF-mediated hyperpolarization and relaxation in coronary arteries. Am J Physiol 1996; 271: H760-H767.
20. He GW, Yang CQ, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg 1995; 59: 676-683.
21. Downing SW, Edmunds LH. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 1236-1243.
22. He GW, Yang CQ, Mack MJ, et al. Interaction between endothelin and vasodilators in the human internal mammary artery. Br J Clin Pharmacol 1994; 37: 173-179.
23. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in the arterial smooth muscle. Am J Physiol 1995; 267: C799-C822.
24. + channels? Trends Pharmacol Sci 1993; 14: 332-337.
25. Jie K, van Brummelen P, Timmermans PB, Thoolen MJ, van Zwieten PA. Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines on the pithed rat. Arch Int Pharmacodyn Ther 1985; 278: 72-86.
26. Hicks PE, Tierney C, Langer SZ. Preferential antagonism by diltiazem of alpha 2-adrenoceptor mediate vasoconstrictor responses in perfused tail arteries of spontaneous hypertensive rats. Naunyn Schiniedeberg's Arch Pharmacol 1985; 328: 388-395.
27. Muller SE. Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine. Naunyn Sclnnicdcburg's Arch Pharmacol 1983; 324: 64-69.
28. Hamilton CA, Jardine E, Reid JL. The effects of calcium antagonists on blood pressure and responses to alpha-adrenoceptor agonists in hypertensive rabbits. Clin Exp Pharmacol Physiol 1987; 14: 77-85.